|
|
||||||||
Eur J Cardiothorac Surg 2005;27:23-27
© 2005 Elsevier Science NL
B decoy transfectionnovel strategy for use in lung transplantation
Department of Surgery (E1), Osaka University Graduate School of Medicine, Yamada-oka 2-2, Suita City, Osaka 565-0871, Japan
Received 20 June 2004; received in revised form 31 August 2004; accepted 3 September 2004.
* Corresponding author. Present Address: Department of General Thoracic Surgery, Kure Medical Center, Aoyamacho 1-3 Kure Hiroshima 737-0023, Japan. Tel.: +81 823 22 3111; fax: +81 823 21 0428. (E-mail: omorik{at}kure-nh.go.jp).
Objective: Increased production of nitric oxide (NO) is known to be a marker of lung allograft rejection and lung injury. NO production is up-regulated directly or indirectly by nuclear factor-kappa B (NF-
B), a transcriptional factor of inflammatory cytokines and iNOS. We attempted to determine whether transfection of an NF-
B decoy into allografts could reduce NO production and ameliorate acute lung injury during allograft rejection. Methods: Left lung transplantation was performed in pairs of Brown Norway (RT1n) and Lewis (RT1) rats. In Group NF (n=6), the allografts were flushed with 20ml of PBS solution containing a hemagglutinating virus of Japan (HVJ) liposome-ODN complex as an NF-
B decoy and preserved for 60min at 4°C. A scramble decoy was used in the positive control (Group S, n=5) and simple PBS solution in the negative control (Group C, n=5). Five days after transplantation without use of immuno-suppressants, exhaled NO, gas exchange, and graft histological rejection score were determined. Results: The exhaled NO level was significantly reduced in Group NF as compared with Group S (445±162 vs 1305±123 ppb, P<0.02), while improvements in PaO2 (197±28 vs. 60±18mmHg, P<0.02) and rejection score (1.8±0.3 vs. 2.5±0.4) were also observed. There were no differences in these parameters between Groups S and C. Conclusions: Inhibition of NF-
B activation in the allograft by ODN decoy transfection into the donor lung ameliorated lung injury during acute allograft rejection. Our results imply a possible therapeutic target for the inflammation process in lung transplantation clinical settings.
Key Words: Allograft lung injury Gene Transfer Lung transplantation NF-
B
This article has been cited by other articles:
![]() |
H. Holschermann, T. H.W. Stadlbauer, A. H. Wagner, H. Fingerhuth, H. Muth, S. Rong, F. Guler, H. Tillmanns, and M. Hecker STAT-1 and AP-1 decoy oligonucleotide therapy delays acute rejection and prolongs cardiac allograft survival Cardiovasc Res, August 1, 2006; 71(3): 527 - 536. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. F. Liu and A. B. Malik NF-{kappa}B activation as a pathological mechanism of septic shock and inflammation Am J Physiol Lung Cell Mol Physiol, April 1, 2006; 290(4): L622 - L645. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ohmori, S.-i. Takeda, S. Miyoshi, M. Minami, S. Nakane, M. Ohta, Y. Sawa, and H. Matsuda Application of HVJ-liposome mediated gene transfer in lung transplantation--distribution and transfection efficiency in the lung Eur. J. Cardiothorac. Surg., May 1, 2005; 27(5): 768 - 773. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |